Lot nr. 4.38 Amplisens Leucosis Quantum M-bcr-FRT PCR kit

Status Purchase has not taken place

Estimated value without VAT 125 416,67 MDL

Period of clarifications: 31 Jul 2024, 11:02 - 12 Aug 2024, 10:00

Submission of proposals: 12 Aug 2024, 10:00 - 6 Sep 2024, 10:00

Auction start date: will not be used

Supplier technical support:

(+373) 79999801

This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Lot nr. 4.38 Amplisens Leucosis Quantum M-bcr-FRT PCR kit

Information about customer

Title

CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE

Fiscal code/IDNO

1016601000212

Address

MD-2005, MOLDOVA, mun.Chişinău, mun.Chişinău, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2

Web site

---

The contact person

Full name

Aurelia Botica

Contact phone

022222364

E-mail

aurelia.botica@capcs.md

Purchase data

Date created

31 Jul 2024, 10:59

Date modified

9 Aug 2024, 11:59

Estimated value (without VAT)

125 416,67 MDL

Achizitii.md ID

21264649

MTender ID

ocds-b3wdp1-MD-1722412794153

Type of procedure

Open tender

Award criteria

The lowest price

Delivery address

MD-2005, MOLDOVA, mun.Chişinău, mun.Chişinău, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2

Contract period

1 Jan 2025 02:00 - 31 Dec 2025 02:00

List of positions

Title

Lot nr. 4.38 Amplisens Leucosis Quantum M-bcr-FRT PCR kit CPV: 33600000-6 - Pharmaceutical products

Quantity: 5.0

Unit of measurement: Bucata

Documents of the procurement procedure

ds_bunuri_servicii_omf_115_15_09_2021.docx

Bidding Documents

31.07.24 11:02

lista de distribuție imuno 2025.xlsx

Bidding Documents

31.07.24 11:02

contract nou.docx

Bidding Documents

31.07.24 11:02

duae_ro_0 (1).doc

Bidding Documents

31.07.24 11:02

anunt de participare ri 09.08.2024.signed.pdf

Bidding Documents

9.08.24 11:59

formularele 09.08.2024.xlsx

Bidding Documents

9.08.24 11:59

The history of the auction

View auction

Unfortunately, questions can be asked only during the "Active" period.

Clarifications